Both in Biotechnology
Cel-Sci vs Metagenomi Therapeutics
Over the past year CVM returned −80.5% and MGX returned −65.5%; their daily moves had a correlation of 0.10.
CVM −80.5% MGX −65.5%Growth of $1, one year, split-adjusted
| Metric | CVM | MGX |
|---|---|---|
| Price | $1.38 | $0.7900 |
| Market cap | $24.3M | $29.8M |
| Today | −2.13% | +3.95% |
| 1 month | −49.6% | −23.3% |
| 6 months | −4.8% | −44.8% |
| Year to date | −73.8% | −51.2% |
| 1 year | −80.5% | −67.4% |
| Revenue growth (YoY) | — | −103.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 2.2× |
| Net cash | $255.6K | $120.7M |
| Dividend yield | — | — |
| Volatility (60d) | 95.5% | 47.8% |
| Short % of float | 4.0% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).